Medulloblastoma and Drop Metastasis: MRI Evaluation and Optimized Protocol
- 26 May 2015
- journal article
- Published by Springer Nature in Current Radiology Reports
- Vol. 3 (7) , 1-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010Neuro-Oncology, 2013
- Subgroup-Specific Prognostic Implications of TP53 Mutation in MedulloblastomaJournal of Clinical Oncology, 2013
- Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical OutcomeJournal of Clinical Oncology, 2011
- Central Nervous System TumorsHematology/Oncology Clinics of North America, 2010
- Beta‐catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristicsThe Journal of Pathology, 2009
- Orally Administered Factor Xa Inhibitor, RivaroxabanNeurosurgery, 2008
- Normal MRI Appearance and Motion-Related Phenomena of CSFAmerican Journal of Roentgenology, 2007
- β-Catenin Status Predicts a Favorable Outcome in Childhood Medulloblastoma: The United Kingdom Children's Cancer Study Group Brain Tumour CommitteeJournal of Clinical Oncology, 2005
- A Clinicobiological Model Predicting Survival in MedulloblastomaClinical Cancer Research, 2004
- Medulloblastoma: Clinical and biologic aspectsNeuro-Oncology, 1999